International Journal of Drug Policy
Volume 13, Issue 3 , Pages 213-224, September 2002

Marketing harm reduction: a historical narrative of the International Harm Reduction Development Program

  • Phillip O Coffin

      Affiliations

    • Corresponding Author InformationTel.: +1-212-822-7274; fax: +1-212-876-6220
    • The Lindesmith Center, Open Society Institute, from 1995–2000.

Center for Urban Epidemiologic Studies, New York Academy of Medicine, 1216 Fifth Avenue, New York, NY 10029, USA

Accepted 10 February 2002.

Abstract 

The International Harm Reduction Development Program (IHRD) was established to develop syringe exchange, methadone maintenance and peer outreach for HIV prevention and health promotion among drug users in Central and Eastern Europe, the Former Soviet Union and Central Asia. This narrative describes the process of program development, since establishment in 1995, through interviews with the three program directors, focusing on the identification of development strategies and obstacles to successful implementation. The goal of IHRD was to establish independent organizations capable of beginning further initiatives in their own and other regions. Few projects were funded in the first 3 years, as IHRD focused on developing a dialogue and network of harm reduction providers. Since 1998, the number of projects funded expanded greatly. It is not possible to evaluate the impact on drug users’ health, but evidence exists to suggest that IHRD played a substantial role in establishing harm reduction as a viable intervention, in attracting other agencies to support harm reduction and in improving the lives of project participants. Although IHRD was originally scheduled to close at the end of 2001, it was granted 3 years of continued operation and continues to expand the number and breadth of programs it funds.

Keywords:  Harm reduction, Central and Eastern Europe, Russia, Central Asia, History

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This article by Phillip Coffin marks the start of a new occasional section of the journal devoted to historical descriptions of policies and organizations.

PII: S0955-3959(02)00078-6

doi:10.1016/S0955-3959(02)00078-6

International Journal of Drug Policy
Volume 13, Issue 3 , Pages 213-224, September 2002